Product Information

INDAPAMIDE 1.25 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1112 per EA under NDC 62559051001. Its NADAC has been published 457 times since Feb 14, 2018.

FDA first approved this application on Jul 27, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

INDAPAMIDE 1.25 MG TABLET

Indapamide
$0.1112per EA

Strength

1.25 mg/1

NDC

62559051001

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

INDAPAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074299

FDA Approved

7/27/1995

TE Code

AB

On Market Since

4/24/2017

Pharmacological Classes

Increased Diuresis
Thiazide-like Diuretic

Price Statistics

The NADAC for INDAPAMIDE 1.25 MG TABLET has been published 457 times since Feb 14, 2018, and over the history we have for it it has declined 51.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1112 per EA
All-time high$0.2284 (Feb 14, 2018)
All-time low$0.0837 (Nov 20, 2024)
52-week high$0.1112
52-week low$0.1034
Median price$0.1240
Average price$0.1383
Largest weekly change-29.9% (Nov 20, 2024)
Weeks tracked457
Tracking sinceFeb 14, 2018

Price History

1W

0.0%

1M

+2.3%

3M

+5.1%

6M

+3.9%

1Y

+7.6%

3Y

-8.0%

5Y

-13.8%

All

-51.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of INDAPAMIDE 1.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for INDAPAMIDE 1.25 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1112 per EA (NDC 62559051001), effective Nov 11, 2026.

How has the price of INDAPAMIDE 1.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for INDAPAMIDE 1.25 MG TABLET has declined 51.3%. It has been tracked across 457 weekly CMS publications since Feb 14, 2018.

What are the highest and lowest recorded NADAC prices for INDAPAMIDE 1.25 MG TABLET?

Since Feb 14, 2018, the NADAC for INDAPAMIDE 1.25 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.2284 (Feb 14, 2018), with a median of $0.1240 per EA.

Are there cheaper alternatives to INDAPAMIDE 1.25 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as INDAPAMIDE 1.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures INDAPAMIDE 1.25 MG TABLET?

INDAPAMIDE 1.25 MG TABLET (NDC 62559051001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.